Nuwellis
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Nuwellis sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Nuwellis: 7 sponsored US clinical trials, 1 recruiting.
Nuwellis sponsors 7 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Heart Failure (for Example, Fluid Overload), with 1 trials.
Upper-quartile sponsor footprint
Nuwellis sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
Ultrafiltration Versus IV Diuretics in Worsening Heart Failure
NCT05318105
Ultrafiltration Therapy Registry Using Aquadex (ULTRA-Peds)
NCT04644731
A Feasibility Study on Ultrafiltration and Blood Volume Measurements
NCT04241718
C-Pulse® System: A Heart Assist Device Clinical Study
NCT01740596
Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment
NCT01474200
C-Pulse IDE Feasibility Study- A Heart Assist System
NCT00815880
Ultrafiltration Versus Intravenous (IV) Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure: (UNLOAD)
NCT00124137
Therapeutic Areas
What is open in the Nuwellis pipeline
1 recruiting of 7 indexed (14% open); 2 completed (29%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Heart Failure (for Example, Fluid Overload) (1 trial), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Nuwellis: open-pipeline peers nationwide
Peers matched on 7 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Nuwellis sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this Nuwellis page
7 registered trials is a research-attention snapshot, not an endorsement of Nuwellis or any single study.
- 1 of Nuwellis's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Heart Failure (for Example, Fluid Overload) is the condition Nuwellis studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Failure (for Example, Fluid Overload) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Nuwellis pipeline card: 7 registered trials from official public datasets.Report a data error.